
|
|
![]() | ![]() | ![]() | ![]() |


IShares NASDAQ Biotechnology Index Fund (IBB) |


Suggest other news sources for this topic

WIKI ANALYSIS| This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
iShares Nasdaq Biotechnology Index Fund (IBB)
OverviewThe iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index®. [1]
Fund Information
Top Holdings| Holdings | % of Portfolio |
| AMGEN INC | 10.55% |
| GILEAD SCIENCES INC | 8.73% |
| TEVA PHARMACEUTICAL-SP ADR | 7.89% |
| CELGENE CORP | 6.35% |
| VERTEX PHARMACEUTICALS INC | 4.10% |
| BIOGEN IDEC INC | 3.02% |
| GENZYME CORP | 3.00% |
| ALEXION PHARMACEUTICALS INC | 2.54% |
| Life Technologies Corp | 2.32% |
| MYLAN INC | 2.29% |
Holdings as of 05/11/2009
Other Bio-Technology ETFs | ETF Name | Fund Manager | Expense Ratio |
| Biotech HOLDRS ETF (BBH) | Merrill Lynch, Pierce, Fenner & Smith HOLDRS | N/A |
| First Trust AMEX Biotechnology Index Fund (FBT) | First Trust Advisors L.P | 0.60% |
| Global Biotech Portfolio ETF (PBTQ) | Invesco PowerShares | 0.75% |
| iShares Nasdaq Biotechnology Index Fund (IBB) | ishares | 0.48% |
| Powershares Dynamic Biotechnology & Genome Portfolio ETF (PBE) | Invesco PowerShares | 0.60% |
| SPDR S&P Biotech ETF (XBI) | State Street Global Markets, LLC | 0.35% |
ReferencesCategories: ETF | Topic | Stock ETFs | Ishares



| |||||||